Shares Bazaar
NSE   0.00  
OPEN PRICE(₹)
0.00
HIGH PRICE(₹)
0.00
LOW PRICE(₹)
0.00
CLOSE PRICE(₹)
0.00
VOLUME
0.00
52 WK LOW (₹)
235.55 (19-03-2020)
52 WK HIGH (₹)
487.75 (23-12-2020)
BSE   395.4  
OPEN PRICE₹)
396.5
HIGH PRICE(₹)
398.5
LOW PRICE (₹)
387.5
CLOSE PRICE(₹)
395.4
VOLUME
91500
VALUE
35898500
BID QTY
0.00
OFFER QTY
0.00

Stock Summary

Trade Value (₹ in Lacs) : 2147.48 MCap (₹ in Mn) : 456000 Dividend Yield(%) : 0 Price/Earning (TTM) : 148.83
TTM EPS (₹) : 0 Price/Sales (TTM) : 0 P/E Ratio : 0.02 Price/Book (MRQ) : 5.87
Book Value(₹) : 0 Face Value(₹) : 0 Latest Reserve (₹ in Mn): 71672 EPSc : 3.67
PE : 103.42 TTMNP : 3064 TTMTAX : 746 TTMINTEREST : 5
TTMDEPRECIATION : 1027 TTMNetSales : 20192 EV_Sales : 22.4 EV (in Mn) : 452261
TTMEBITDA : 4615 EV_EBITDA : 98 TTMCashProfit : 4091 TTMCEPS : 3.41
Price_CEPS : 111.46 TTMNPAEX : 3064

Peer Group Compare

Comp. Name Price M.Cap Div Yld % P/E Ratio Price/Earning (TTM) TTM EPS (₹)
Sun Pharmaceutical Industries Ltd. (BSE)

604.3 ( 1.51%)

135418.47 0.71 0 47 12.01
Divis Laboratories Ltd. (BSE)

3462.8 ( 2.81%)

91003.96 0.47 0.06 51.76 66.23
Dr. Reddys Laboratories Ltd. (BSE)

4453.3 ( 0.65%)

81092.78 0.51 0.04 33.02 147.67
Cipla Ltd. (BSE)

789.5 ( 0.38%)

67867.68 0.48 0.01 30.26 27.81
Aurobindo Pharma Ltd. (BSE)

873.2 ( 2.14%)

55333.11 0.32 0.01 20.8 45.4

Management Info

Chairman : Kiran Muzumdar Shaw
Managing Director : Siddharth Mittal
Company Secretory : Mayank Verma
Incorporation Year : 1978

Registered Office

Address : 20th Km
Hosur Road
Electronic City
City-Pincode : Bengaluru-560100
Phone : 080 2808 2808
Website : www.biocon.com
Email : corporate.communications@biocon.com

Registrars Details

Registrars Details : K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Address : Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: einward.ris@karvy.comWebsite: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001
Listing : BSE, NSE, MCX

loading..

Balance Sheet

(₹ in Million)
Particulars Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016
SOURCES OF FUNDS:
Share Capital 6 3 3 1 1
  Equity - Authorised 6 3 3 1.1 1.1
  Equity - Issued 6 3 3 1 1
 Equity Paid Up 6 3 3 1 1
  Equity Shares Forfeited 0.00 0.00 0.00 0.00 0.00
  Adjustments to Equity 0.00 0.00 0.00 0.00 0.00
  Preference Capital Paid Up 0 0 0.00 0.00 0.00
  Face Value 0.01 0.01 0.01 0.01 0.01
Share Warrants & Outstandings 0.00 0.00 0.00 0.00 0.00
Total Reserves 59.97 57.21 48.12 46.7 39.34
  Securities Premium 0.24 1.17 1.03 2.91 2.79
  Capital Reserves 0.8 0.8 0.8 0.8 0.83
  Profit & Loss Account Balances 59.14 52.09 42.29 39.03 31.67
  General Reserves 1.62 3.46 3.46 3.46 3.46
Reserve excluding Revaluation Reserve 59.96 57.2 48.11 46.69 39.33
Revaluation Reserves 0.01 0.01 0.01 0.01 0.01
Deposits 0.00 0.00 0.00 0.00 0.00
  Demand Deposits 0.00 0.00 0.00 0.00 0.00
  Savings Deposit 0.00 0.00 0.00 0.00 0.00
  Term Deposits / Fixed Deposits 0.00 0.00 0.00 0.00 0.00
  Current Deposits 0.00 0.00 0.00 0.00 0.00
  Recurring Deposits 0.00 0.00 0.00 0.00 0.00
  Other Deposits 0.00 0.00 0.00 0.00 0.00
Borrowings 0.00 0.00 0.00 0.00 0.00
  Borrowings From Reserve Bank of India 0.00 0.00 0.00 0.00 0.00
  Borrowings From Other Banks 0.00 0.00 0.00 0.00 0.00
  Borrowings From GOI 0.00 0.00 0.00 0.00 0.00
  Borrowings From Other Financial Institutions 0.00 0.00 0.00 0.00 0.00
  Borrowings in the form of Bonds / Debentures 0.00 0.00 0.00 0.00 0.00
  Borrowings in Other Form 0.00 0.00 0.00 0.00 0.00
Other Liabilities & Provisions 0.00 0.00 0.00 0.00 0.00
  Bills Payable 0.00 0.00 0.00 0.00 0.00
  Inter-office adjustment Liabilities 0.00 0.00 0.00 0.00 0.00
  Interest Accrued 0.00 0.00 0.00 0.00 0.00
  Proposed Dividend 0.00 0.00 0.00 0.00 0.00
  Corporate dividend tax payable 0.00 0.00 0.00 0.00 0.00
  Other Liabilities & Provisions 0.86 0.66 0.49 0.36 0.3
Total Liabilities 104.06 91.54 78.48 77.16 67.92
APPLICATION OF FUNDS :
Cash and balance with Reserve Bank of India 0.00 0.00 0.00 0.00 0.00
  Cash with RBI 0.00 0.00 0.00 0.00 0.00
  Cash in hand & others 0.00 0.00 0.00 0.00 0.00
Balances with banks and money at call 0.00 0.00 0.00 0.00 0.00
Investments 14.41 14.39 12.57 17.5 13.03
Investments in India 0.00 0.00 0.00 0.00 0.00
  GOI/State Govt. Securities 0.00 0.00 0.00 0.00 0.00
  Equity Shares - Corporate 0.00 0.00 0.00 0.00 0.00
  Debentures & Bonds 0.00 0.00 0.00 0.00 0.00
  Subsidiaries and/or joint ventures/Associates 0.00 0.00 0.00 0.00 0.00
  Units - MF/ Insurance/CP/PTC 0.00 0.00 0.00 0.00 0.00
Investments outside India 0.00 0.00 0.00 0.00 0.00
  Government securitiesC 0.00 0.00 0.00 0.00 0.00
  Subsidiaries and/or joint ventures abroad 0.00 0.00 0.00 0.00 0.00
  Other investments outside India 0.00 0.00 0.00 0.00 0.00
  Less: Prov for Diminution in Value of Invest. 0.00 0.00 0.00 0.00 0.00
Advances 0.00 0.00 0.00 0.00 0.00
  Bills Purchased & Discounted 0.00 0.00 0.00 0.00 0.00
  Cash Credit, Over Draft & Loans repayable 0.00 0.00 0.00 0.00 0.00
  Term Loans 0.00 0.00 0.00 0.00 0.00
  Finance lease and hire purchase receivable 0.00 0.00 0.00 0.00 0.00
Gross block 91.47 70.95 58.74 54.36 34.04
  Premises 19.34 14.34 13.37 12.79 6.61
  Assets Given on Lease 0.00 0.00 0.00 0.00 0.00
  Other Fixed Assets 0.16 0.16 0.7 0.58 0.41
Less: Accumulated Depreciation 31.76 26.24 21.74 18.11 16.55
Net Block 59.71 44.71 37 36.25 17.48
Less: Impairment of Assets 0.00 0.00 0.00 0.00 0.00
Lease Adjustment 0.00 0.00 0.00 0.00 0.00
Capital Work in Progress 21.96 18.99 13.03 8.39 22.4
Other Assets 0.00 0.00 0.00 0.00 0.00
  Inter-office adjustment Assets 0.00 0.00 0.00 0.00 0.00
  Interest Accrued Assets 0.00 0.00 0.00 0.00 0.00
  Tax paid in advance/TDS 0.00 0.00 0.00 0.00 0.00
  Stationery and stamps 0.00 0.00 0.00 0.00 0.00
  Non-banking assets acquired 0.00 0.00 0.00 0.00 0.00
  Deferred tax asset 0.00 0.00 0.00 0.00 0.00
  Miscellaneous Expenditure not written off 0.00 0.00 0.00 0.00 0.00
Total Assets 104.06 91.54 78.48 77.16 67.92
Contingent Liabilities 7.17 8.11 5.89 11.21 5.91
  Claims not acknowledged as debts 7.02 7.9 5.72 10.54 5.2
  Outstanding forward exchange contracts 0.00 0.00 0.00 0.00 0.00
  Guarantees given in India 0.00 0.00 0.00 0.00 0.00
  Guarantees given Outside India 0.00 0.00 0.00 0.00 0.00
  Acceptances, endorsements & other obligations 0.00 0.00 0.00 0.00 0.00
Bills for collection 0.00 0.00 0.00 0.00 0.00
Book Value 0.05 0.1 0.09 0.24 0.2
Adjusted Book Value 0.05 0.05 0.04 0.04 0.03
(₹ in Million)
Particulars Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016
SOURCES OF FUNDS:
Share Capital 6 3 3 1 1
  Equity - Authorised 6 3 3 1.1 1.1
  Equity - Issued 6 3 3 1 1
 Equity Paid Up 6 3 3 1 1
  Equity Shares Forfeited 0.00 0.00 0.00 0.00 0.00
  Adjustments to Equity 0.00 0.00 0.00 0.00 0.00
  Preference Capital Paid Up 0.00 0.00 0.00 0.00 0.00
  Face Value 0.01 0.01 0.01 0.01 0.01
Share Warrants & Outstandings 0.00 0.00 0.00 0.00 0.00
Total Reserves 68.54 67.56 63.89 63.97 58.97
  Securities Premium 0.24 1.17 1.03 2.91 2.79
  Capital Reserves 0 0 0 0 -0.14
  Profit & Loss Account Balances 67.95 63.92 60.21 58.24 52.86
  General Reserves 1.62 3.46 3.46 3.46 3.46
Reserve excluding Revaluation Reserve 68.53 67.55 63.88 63.96 58.96
Revaluation Reserves 0.01 0.01 0.01 0.01 0.01
Deposits 0.00 0.00 0.00 0.00 0.00
  Demand Deposits 0.00 0.00 0.00 0.00 0.00
  Savings Deposit 0.00 0.00 0.00 0.00 0.00
  Term Deposits / Fixed Deposits 0.00 0.00 0.00 0.00 0.00
  Current Deposits 0.00 0.00 0.00 0.00 0.00
  Recurring Deposits 0.00 0.00 0.00 0.00 0.00
  Other Deposits 0.00 0.00 0.00 0.00 0.00
Borrowings 0.00 0.00 0.00 0.00 0.00
  Borrowings From Reserve Bank of India 0.00 0.00 0.00 0.00 0.00
  Borrowings From Other Banks 0.00 0.00 0.00 0.00 0.00
  Borrowings From GOI 0.00 0.00 0.00 0.00 0.00
  Borrowings From Other Financial Institutions 0.00 0.00 0.00 0.00 0.00
  Borrowings in the form of Bonds / Debentures 0.00 0.00 0.00 0.00 0.00
  Borrowings in Other Form 0.00 0.00 0.00 0.00 0.00
Other Liabilities & Provisions 0.00 0.00 0.00 0.00 0.00
  Bills Payable 0.00 0.00 0.00 0.00 0.00
  Inter-office adjustment Liabilities 0.00 0.00 0.00 0.00 0.00
  Interest Accrued 0.00 0.00 0.00 0.00 0.00
  Proposed Dividend 0.00 0.00 0.00 0.00 0.00
  Corporate dividend tax payable 0.00 0.00 0.00 0.00 0.00
  Other Liabilities & Provisions 0.21 0.25 0.17 0.13 0.1
Total Liabilities 75.83 72.47 68.95 67.64 62.35
APPLICATION OF FUNDS :
Cash and balance with Reserve Bank of India 0.00 0.00 0.00 0.00 0.00
  Cash with RBI 0.00 0.00 0.00 0.00 0.00
  Cash in hand & others 0.00 0.00 0.00 0.00 0.00
Balances with banks and money at call 0.00 0.00 0.00 0.00 0.00
Investments 53.14 43.27 48.44 43.75 42.59
Investments in India 0.00 0.00 0.00 0.00 0.00
  GOI/State Govt. Securities 0.00 0.00 0.00 0.00 0.00
  Equity Shares - Corporate 0.00 0.00 0.00 0.00 0.00
  Debentures & Bonds 0.00 0.00 0.00 0.00 0.00
  Subsidiaries and/or joint ventures/Associates 0.00 0.00 0.00 0.00 0.00
  Units - MF/ Insurance/CP/PTC 0.00 0.00 0.00 0.00 0.00
Investments outside India 0.00 0.00 0.00 0.00 0.00
  Government securitiesC 0.00 0.00 0.00 0.00 0.00
  Subsidiaries and/or joint ventures abroad 0.00 0.00 0.00 0.00 0.00
  Other investments outside India 0.00 0.00 0.00 0.00 0.00
  Less: Prov for Diminution in Value of Invest. 0.00 0.00 0.00 0.00 0.00
Advances 0.00 0.00 0.00 0.00 0.00
  Bills Purchased & Discounted 0.00 0.00 0.00 0.00 0.00
  Cash Credit, Over Draft & Loans repayable 0.00 0.00 0.00 0.00 0.00
  Term Loans 0.00 0.00 0.00 0.00 0.00
  Finance lease and hire purchase receivable 0.00 0.00 0.00 0.00 0.00
Gross block 18.85 25.27 21.82 20.82 19.34
  Premises 3.93 4.08 3.96 3.91 3.82
  Assets Given on Lease 0.00 0.00 0.00 0.00 0.00
  Other Fixed Assets 0.08 0.08 0.08 0.08 0.08
Less: Accumulated Depreciation 11.64 14.67 13.23 11.88 10.41
Net Block 7.21 10.59 8.59 8.94 8.94
Less: Impairment of Assets 0 0 0 0 0
Lease Adjustment 0.00 0.00 0.00 0.00 0.00
Capital Work in Progress 1.52 2.55 3.19 2.41 1.72
Other Assets 0.00 0.00 0.00 0.00 0.00
  Inter-office adjustment Assets 0.00 0.00 0.00 0.00 0.00
  Interest Accrued Assets 0.00 0.00 0.00 0.00 0.00
  Tax paid in advance/TDS 0.00 0.00 0.00 0.00 0.00
  Stationery and stamps 0.00 0.00 0.00 0.00 0.00
  Non-banking assets acquired 0.00 0.00 0.00 0.00 0.00
  Deferred tax asset 0.00 0.00 0.00 0.00 0.00
  Miscellaneous Expenditure not written off 0.00 0.00 0.00 0.00 0.00
Total Assets 75.83 72.47 68.95 67.64 62.35
Contingent Liabilities 20.47 18.25 16.93 16.69 15.33
  Claims not acknowledged as debts 1.79 3.39 3.3 2.89 3.04
  Outstanding forward exchange contracts 0.00 0.00 0.00 0.00 0.00
  Guarantees given in India 0.00 0.00 0.00 0.00 0.00
  Guarantees given Outside India 0.00 0.00 0.00 0.00 0.00
  Acceptances, endorsements & other obligations 0.00 0.00 0.00 0.00 0.00
Bills for collection 0.00 0.00 0.00 0.00 0.00
Book Value 0.06 0.12 0.11 0.32 0.3
Adjusted Book Value 0.06 0.06 0.06 0.05 0.05

Quarterly Results

Particulars Sep-2020 Jun-2020 Mar-2020 Feb-2019
Date End Audited Audited Audited Audited
Interest Earned 17448.00 16713.00 15810.00 17481.00
Income On Investments 0.00 0.00 0.00 0.00
Interest On Balances With Rbi Other Inter Bank Funds 0.00 0.00 0.00 0.00
Interest / Discount On Advances / Bills 0 0 0 0
Others 0 0 0 0
Other Income 155 183 631 358
Total Income 17603 16896 16441 17839
Interest Expended 65 125 168 177
Operating Expenses 0 0 0 0
Total Expenditure 13534 12580 12624 13039
Operating Profit Before Provisions and Contingencies 4069 4316 3817 4800
Exceptional Items 0 0 0 0
Provisions and contingencies 0 0 0 0
Profit Before Tax 2227 2523 2125 3183
Tax 223 809 450 848
Profit After Tax 2004 1714 1675 2335
+/- Extraordinary Items 0 0 0 0
+/- Prior period items 0 0 0 0
Net Profit 2004 1714 1675 2335
Minority Interest -261 -184 -357 -275
Shares of Associates -50 -36 -84 -32
Other related items 0 0 0 0
Misc. Expenses Written off 0.00 0.00 0.00 0.00
Consolidated Net Profit 2004 1714 1675 2335
Equity Capital 1693 1494 1234 2028
Face Value (IN RS) 5 5 5 5
Reserves 0 0 0 0
% of Shares held by Govt 0 0 0 0
Capital Adequacy Ratio 0.00 0.00 0.00 0.00
Gross / Net NPAs 0.00 0.00 0.00 0.00
Amount of Gross NPAs 0.00 0.00 0.00 0.00
Amount of Net NPAs 0 0 0 0
% of Gross / Net NPAs NA NA NA NA
% of Net NPAs 0 0 0 0
% of Gross NPAs 0 0 0 0
Return on Assets 0 0 0 0
No of Public Share Holdings NA NA NA NA
% of Public Share Holdings NA NA NA NA
Basic Eps After Extraordinary Items 1.47 1.26 1.04 1.71
Basic Eps Before Extraordinary Items 1.47 1.26 1.04 1.71
PBIDTM% 23.32 25.82 24.14 27.46
PBDTM% 22.95 25.08 23.08 26.45
PBTM% 12.76 15.1 13.44 18.21
PATM% 11.49 10.26 10.59 13.36
Particularsaaa Jun-2020 Mar-2020
Date End Audited Audited
Interest Earned 5207.0 4824.0
Income On Investments 0 0
Interest On Balances With Rbi Other Inter Bank Funds 0 0
Interest / Discount On Advances / Bills 0 0
Others 0.00 0.00
Other Income 360 672
Total Income 5567 5496
Interest Expended 1 2
Operating Expenses 0.00 0.00
Total Expenditure 4040 4390
Operating Profit Before Provisions and Contingencies 1527 1106
Exceptional Items 0 227
Provisions and contingencies 0.00 0.00
Profit Before Tax 1269 1085
Tax 421 149
Profit After Tax 848 936
+/- Extraordinary Items 0.00 0.00
+/- Prior period items 0.00 0.00
Net Profit 848 1022
Minority Interest 0.00 0.00
Shares of Associates 0.00 0.00
Other related items 0.00 0.00
Misc. Expenses Written off 0.00 0.00
Consolidated Net Profit 848 1022
Equity Capital 848 1022
Face Value (IN RS) 5 5
Reserves 0 0
% of Shares held by Govt 0.00 0.00
Capital Adequacy Ratio 0.00 0.00
Gross / Net NPAs 0.00 0.00
Amount of Gross NPAs 0.00 0.00
Amount of Net NPAs 0.00 0.00
% of Gross / Net NPAs NA NA
% of Net NPAs 0.00 0.00
% of Gross NPAs 0.00 0.00
Return on Assets 0.00 0.00
No of Public Share Holdings NA NA
% of Public Share Holdings NA NA
Basic Eps After Extraordinary Items 0.72 0.79
Basic Eps Before Extraordinary Items 0.72 0.79
PBIDTM% 29.33 22.93
PBDTM% 29.31 27.59
PBTM% 24.37 22.49
PATM% 16.29 19.4

Profit-Loss

-
Particulars Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016
I. INCOME
Interest Earned 0 0 0 0 0
     Interest / Discount on advances / Bills 0 0 0 0 0
     Interest on balances with RBI and other Inter-bank funds 0 0 0 0 0
     Income on investments 0 0 0 0 0
     Others 0 0 0 0 0
Other Income
     Commission,exchange and brokerage 0 0 0 0 0
     Profit / (loss)on sale of investments(net) 0.09 0.22 0.58 0.04 0.02
     Profit on sale of Fixed Assets 0 0 0 0 0
     Foreign Exchange Gains 0.65 0.28 0.83 0 0
     Income earned from subsidiaries/joint venture 0 0 0 0 0
     Rent / Lease Income
     Provisions Written Back 0 0 0 0 0
     Miscellaneous income -10150 -4143 -2062 0 0
Total Income 68.75 59.29 43.3 40.48 34.27
II. EXPENDITURE
Interest Expended 0.65 0.71 0.62 0.26 0.29
     Intereston Deposits 0 0 0 0 0
     Interest on RBI / inter-bank borrowings 0 0 0 0 0
     Other Interest 0.65 0.71 0.62 0.26 0.26
Operating Expenses 0 0 0 0 0
     Payments to and provisions for employees 14.59 11.65 9.31 7.47 6.1
     Rent,Taxes and lighting 0.29 0.46 0.52 0.26 0.22
     Depreciation on Banks property 5.52 4.48 3.85 2.77 2.49
     Depreciation on leased assets
     Auditor's fees and expenses 0.02 0.01 0.01 0.01 0.02
     Law charges 1.1 0.84 0.77 0.57 0.53
     Communication Expenses 0.06 0.07 0.06 0.06 0.06
     Repairs and Maintenance 0 0 0 0 0
     Insurance 0.34 0.24 0.2 0.07 0.06
     Other expenses -21.92 -17.76 -14.72 -11.21 -9.47
Provisions and Contingencies
     Provision for investments
     Provision for advances
     Others Provisions
Profit Before Tax 68.1 58.58 42.68 40.22 33.97
Taxes
     Current Income Tax 2.71 2.04 1.52 2.08 1.81
     Deferred Tax 0.81 0.22 0.31 -0.1 -0.23
     Other taxes 0 0 0 0 0
Profit After Tax 9 10.02 4.32 6.72 5.87
Extra items
Minority Interest -1.23 -0.97 -0.81 -0.76 -0.59
Share of Associate -0.29 0.01 0.21 0.16 0.22
Other Consolidated Items
Consolidated Net Profit 7.48 9.05 3.72 6.12 5.5
Adjustments to PAT -0 -1.61 0.81 1.4 3.26
IV. APPROPRIATIONS
     Transfer to Statutory Reserve
     Appropriation to General Reserve
     Appropriation to Revenue Reserve
     Appropriation to Other Reserves 0.43 -2.35 1.27 0.16 1.15
     Equity Dividend
     Corporate dividend tax
     Other appropriations 59.14 52.09 42.29 39.03 31.67
Equity Dividend % 20.00 20.00 60.00 100.00
Earnings Per Share 6.2350 15.0883 6.2067 30.6050 27.5200
Adjusted EPS 6.2350 7.5442 3.1033 5.1008 4.5867
-
Particulars Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016
I. INCOME
Interest Earned 0 0 0 0 0
     Interest / Discount on advances / Bills 0 0 0 0 0
     Interest on balances with RBI and other Inter-bank funds 0 0 0 0 0
     Income on investments 0 0 0 0 0
     Others 0 0 0 0 0
Other Income
     Commission,exchange and brokerage 0 0 0 0 0
     Profit / (loss)on sale of investments(net) 0.04 0.17 0.29 0.04 0.02
     Profit on sale of Fixed Assets 0 0 0.03 0 0
     Foreign Exchange Gains 0.32 0.05 0.17 0 0.16
     Income earned from subsidiaries/joint venture 0 0 0 0 0
     Rent / Lease Income
     Provisions Written Back 0 0 0 0 0
     Miscellaneous income -6138 -3279 -3741 -1976 -5193
Total Income 23.89 30.03 25.44 26.87 24.75
II. EXPENDITURE
Interest Expended 0.01 0.03 0.01 0.04 0.02
     Intereston Deposits 0 0 0 0 0
     Interest on RBI / inter-bank borrowings 0 0 0 0 0
     Other Interest 0.01 0.03 0.01 0.04 0.01
Operating Expenses 0 0 0 0 0
     Payments to and provisions for employees 3.45 2.89 4.09 3.65 3.22
     Rent,Taxes and lighting 0.12 0.11 0.2 0.21 0.2
     Depreciation on Banks property 0.98 0.92 1.36 1.51 1.4
     Depreciation on leased assets
     Auditor's fees and expenses 0.01 0.01 0.01 0.01 0.01
     Law charges 0.22 0.32 0.3 0.26 0.38
     Communication Expenses 0.02 0.03 0.04 0.04 0.04
     Repairs and Maintenance 0 0 0 0 0
     Insurance 0.15 0.06 0.05 0.03 0.03
     Other expenses -4.95 -4.34 -6.04 -5.7 -5.27
Provisions and Contingencies
     Provision for investments
     Provision for advances
     Others Provisions
Profit Before Tax 23.88 30 25.43 26.83 24.73
Taxes
     Current Income Tax 0.86 1.23 0.61 1.27 2.18
     Deferred Tax 0.08 -0.1 0.01 0.07 -0.27
     Other taxes 0 0 0 0 0
Profit After Tax 4.41 4.93 2.39 5.19 3.69
Extra items
Minority Interest
Share of Associate
Other Consolidated Items
Consolidated Net Profit 4.41 4.93 2.39 5.19 3.69
Adjustments to PAT -0 -0.14 0.27 0.36 0.1
IV. APPROPRIATIONS
     Transfer to Statutory Reserve
     Appropriation to General Reserve
     Appropriation to Revenue Reserve
     Appropriation to Other Reserves 0.38 1.07 0.69 0.16 0
     Equity Dividend
     Corporate dividend tax
     Other appropriations 67.95 63.92 60.21 58.24 53.97
Equity Dividend % 0 20 20 60 100
Earnings Per Share 3.67 8.21 3.98 25.96 18.43
Adjusted EPS 3.67 4.11 1.99 4.33 3.07

Financial Ratios

Particulars Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016
Operational & Financial Ratios
Earnings Per Share (Rs) 6.24 15.09 6.21 30.61 27.52
DPS(Rs) 0 1 1 3 5
Book NAV/Share(Rs) 54.97 100.33 85.19 238.47 201.65
Margin Ratios
Yield on Advances 0 0 0 0 0
Yield on Investments 0 0 0 0 0
Cost of Liabilities 0 0 0 0 0
NIM 0 0 0 0 0
Interest Spread 0 0 0 0 0
Performance Ratios
ROA(%) 6.94 9.25 4.55 7.64 7.96
ROE(%) 14.26 18 8.74 15.26 16.17
ROCE(%) 14.35 16.11 8.92 12.59 13.93
Efficiency Ratios
Cost Income Ratio 0 0 0 0 0
Core Cost Income Ratio 0 0 0 0 0
Operating Costs to Assets 0 0 0 0 0
Capital Adequacy
Basel I
Total CAR (Basel I) 0 0 0 0 0
Tier-1 (Basel I) 0 0 0 0 0
Tier-2 (Basel I) 0 0 0 0 0
Basel II
Total CAR (Basel II) 0 0 0 0 0
Tier-1 (Basel II) 0 0 0 0 0
Tier-2 (Basel II) 0 0 0 0 0
Basel III
Total CAR (Basel III) 0 0 0 0 0
Tier - 1 (Basel III) 0 0 0 0 0
Tier - 2 (Basel III) 0 0 0 0 0
Valuation Parameters
PER(x) 43.4 20.25 47.87 6.17 2.92
PCE(x) 22.36 25.29 43.64 23.89 11.53
Price/Book(x) 4.92 6.09 6.97 4.75 2.39
Yield(%) 0 0.16 0.17 0.26 1.04
EV/Net Sales(x) 5.36 6.89 8.87 6.15 3.16
EV/Core EBITDA(x) 19.32 24.71 35.35 21.05 12.49
EV/EBIT(x) 26.64 29.58 56.28 27.84 13.94
EV/CE(x) 2.42 3.2 3.74 2.6 1.26
M Cap / Sales 5.1 6.65 8.65 5.83 2.88
Growth Ratio
Core Operating Income Growth -8.46 15.28 136.54 -11.26 229.21
Operating Profit Growth 14.72 48.57 -8.91 34.19 13.1
Net Profit Growth -10.17 131.98 -35.72 14.37 11.17
BVPS Growth -45.21 17.77 -64.28 18.26 24.79
Advances Growth 0 0 0 0 0
EPS Growth(%) -58.68 143.1 -79.72 11.21 10.66
Liquidity Ratios
Loans/Deposits(x) 0 0 0 0 0
Total Debt/Equity(x) 0 0 0 0 0
Current Ratio(x) 0 0 0 0 0
Quick Ratio(x) 0 0 0 0 0
Interest Cover(x)
Total Debt/Mcap(x) 0 0 0 0 0
Net NPA in Rs. Million 0 0 0 0 0
Particulars Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016
Operational & Financial Ratios
Earnings Per Share (Rs) 3.67 8.21 3.97 25.97 18.43
DPS(Rs) 0 1 1 3 5
Book NAV/Share(Rs) 62.11 100 100 100 100
Margin Ratios
Yield on Advances 0 0 0 0 0
Yield on Investments 0 0 0 0 0
Cost of Liabilities 0 0 0 0 0
NIM 0 0 0 0 0
Interest Spread 0 0 0 0 0
Performance Ratios
ROA(%) 5.45 6.29 3.18 7.18 7.07
ROE(%) 6.08 7.17 3.62 8.31 8.62
ROCE(%) 7.62 7.89 4.53 8.28 12.43
Efficiency Ratios
Cost Income Ratio 0 0 0 0 0
Core Cost Income Ratio 0 0 0 0 0
Operating Costs to Assets 0 0 0 0 0
Capital Adequacy
Basel I
Total CAR (Basel I) 0 0 0 0 0
Tier-1 (Basel I) 0 0 0 0 0
Tier-2 (Basel I) 0 0 0 0 0
Basel II
Total CAR (Basel II) 0 0 0 0 0
Tier-1 (Basel II) 0 0 0 0 0
Tier-2 (Basel II) 0 0 0 0 0
Basel III
Total CAR (Basel III) 0 0 0 0 0
Tier - 1 (Basel III) 0 0 0 0 0
Tier - 2 (Basel III) 0 0 0 0 0
Valuation Parameters
PER(x) 73.65 37.2 74.74 7.28 4.36
PCE(x) 60.26 62.67 95.17 33.84 18.97
Price/Book(x) 4.36 5.2 5.33 3.49 1.61
Yield(%) 0 0.16 0.17 0.26 1.04
EV/Net Sales(x) 14.7 12.57 14.71 8.66 4.07
EV/Core EBITDA(x) 64.27 81.14 80.35 32.47 15.75
EV/EBIT(x) 57.21 65.58 100 41.52 16.69
EV/CE(x) 3.95 4.53 4.67 3.04 1.32
M Cap / Sales 14.87 12.67 14.74 8.76 4.19
Growth Ratio
Core Operating Income Growth -53.85 100 -73.68 100 100
Operating Profit Growth 11.4 1.22 -35.87 16.09 2.75
Net Profit Growth -10.51 100 -54.07 40.88 2.05
BVPS Growth -47.18 5.49 -65.68 8.35 100
Advances Growth 0 0 0 0 0
EPS Growth(%) -55.26 100 -84.69 40.88 2.05
Liquidity Ratios
Loans/Deposits(x) 0 0 0 0 0
Total Debt/Equity(x) 0 0 0 0 0
Current Ratio(x) 0 0 0 0 0
Quick Ratio(x) 0 0 0 0 0
Interest Cover(x)
Total Debt/Mcap(x) 0 0 0 0 0
Net NPA in Rs. Million 0 0 0 0 0

Cash Flow

(₹ in Million)
Particulars Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016
Net Profit Before Taxes 8.71 10.03 6.1 8.5 7.51
Adjustments for Expenses & Provisions : 9.21 4.73 3.56 2.04 0.42
Adjustments for Liabilities & Assets: -1.65 -0.29 -1.07 -2.11 -1.76
Refund/(payment) of direct taxes -3.44 -2.92 -1.97 -2.03 -2.47
Other Direct payments 0 0 0 0 0
Cash Flow from operating activities 12.83 11.55 6.62 6.4 3.71
Cash Flow from investing activities -15.59 -7.14 -6.84 -4.99 -11.42
Cash Flow from financing activities 3.88 -2.42 -2.4 -1.78 10.68
Effect of exchange fluctuation on translation reserve 0 0 0 0 0
Net increase/(decrease) in cash and cash equivalents 1.12 1.99 -2.62 -0.36 2.97
Opening Cash & Cash Equivalents 6.59 4.49 7.1 7.58 4.58
Cash & Cash Equivalent on Amalgamation / Take over / Merger 0 0 0 0 0
Cash & Cash Equivalent of Subsidiaries under liquidations 0 0 0 0 0
Translation adjustment on reserves / op cash balalces frgn subsidiaries 0 0 0 0 0
Effect of Foreign Exchange Fluctuations 0.54 0.11 0 -0.11 0.04
Closing Cash & Cash Equivalent 8.25 6.59 4.49 7.1 7.58
Cash & Cash Equivalent on Amalgamation / Take over / Merger 0 0 0 0 0
Cash & Cash Equivalent of Subsidiaries under liquidations 0 0 0 0 0
Translation adjustment on reserves / op cash balalces frgn subsidiaries 0 0 0 0 0
Effect of Foreign Exchange Fluctuations 0.54 0.11 0 -0.11 0.04
(₹ in Million)
Particulars Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016
Net Profit Before Taxes 8.71 10.03 6.1 8.5 7.51
Adjustments for Expenses & Provisions : 9.21 4.73 3.56 2.04 0.42
Adjustments for Liabilities & Assets: -1.65 -0.29 -1.07 -2.11 -1.76
Refund/(payment) of direct taxes -3.44 -2.92 -1.97 -2.03 -2.47
Other Direct payments 0 0 0 0 0
Cash Flow from operating activities 12.83 11.55 6.62 6.4 3.71
Cash Flow from investing activities -15.59 -7.14 -6.84 -4.99 -11.42
Cash Flow from financing activities 3.88 -2.42 -2.4 -1.78 10.68
Effect of exchange fluctuation on translation reserve 0 0 0 0 0
Net increase/(decrease) in cash and cash equivalents 1.12 1.99 -2.62 -0.36 2.97
Opening Cash & Cash Equivalents 6.59 4.49 7.1 7.58 4.58
Cash & Cash Equivalent on Amalgamation / Take over / Merger 0 0 0 0 0
Cash & Cash Equivalent of Subsidiaries under liquidations 0 0 0 0 0
Translation adjustment on reserves / op cash balalces frgn subsidiaries 0 0 0 0 0
Effect of Foreign Exchange Fluctuations 0.54 0.11 0 -0.11 0.04
Closing Cash & Cash Equivalent 8.25 6.59 4.49 7.1 7.58
Cash & Cash Equivalent on Amalgamation / Take over / Merger 0 0 0 0 0
Cash & Cash Equivalent of Subsidiaries under liquidations 0 0 0 0 0
Translation adjustment on reserves / op cash balalces frgn subsidiaries 0 0 0 0 0
Effect of Foreign Exchange Fluctuations 0.54 0.11 0 -0.11 0.04

Share Price

Year Open Price (₹) High Price (₹) Low Price (₹) Close Price (₹) Volume (000's) Value (in Lakhs)
February-2021 372.05 417.9 363.3 408.25 4705.41 18897.4
January-2021 467.5 480 368.45 372.05 6571.37 27755.91
December-2020 431.15 487.7 427.6 458.7 4106.72 18775.08
November-2020 403.6 443.65 395.6 429.35 3831.67 16109
October-2020 451.4 477.9 389.8 403.6 3136.72 13679.46
September-2020 382.05 463.55 379 447.75 6740.8 28579.09
August-2020 410.5 418.8 372.65 376.4 3965.1 15892.08
Biocon informs about press release01-Mar-2021 10:21 AM  
Biocon informs about analyst meet18-Feb-2021 12:44 PM  
Biocon informs about press release16-Feb-2021 10:26 AM  
Biocon rises as its arm enters into partnership with International Diabetes Federation 16-Feb-2021 10:13 AM  
Biocon’s arm enters into partnership with International Diabetes Federation16-Feb-2021 09:38 AM  
Biocon gains as its arm, Viatris receive European Commission approval for Kixelle12-Feb-2021 11:20 AM  
Biocon informs about company statement12-Feb-2021 09:49 AM  
Biocon’s arm, Viatris receive European Commission approval for Kixelle12-Feb-2021 09:24 AM  
Biocon declines on reporting 18% fall in Q3 consolidated net profit22-Jan-2021 03:07 PM  
Biocon reports 18% fall in Q3 consolidated net profit22-Jan-2021 11:30 AM  
Biocon shines as its arm receives Rs 555 crore capital injection from ADQ 08-Jan-2021 09:42 AM  
Biocon’s arm receives Rs 555 crore capital injection from ADQ08-Jan-2021 09:08 AM  
Biocon gains on launching Tacrolimus capsules in US29-Dec-2020 10:07 AM  
Biocon launches Tacrolimus capsules in US28-Dec-2020 04:51 PM  
Biocon informs about press release28-Dec-2020 04:40 PM  
Biocon rises as its arm signs MoU with CSSC for Mission 10 cents 16-Dec-2020 09:23 AM  
Biocon’s arm raises Rs 1125 crore through OCDs10-Dec-2020 11:22 AM  
Biocon inches up on entering into agreement to acquire stake in HRTPL24-Nov-2020 09:55 AM  
Biocon enters into agreement to acquire stake in HRTPL23-Nov-2020 03:55 PM